Palvella Therapeutics (PVLA) Return on Equity (2016 - 2024)
Historic Return on Equity for Palvella Therapeutics (PVLA) over the last 11 years, with Q3 2024 value amounting to 0.0%.
- Palvella Therapeutics' Return on Equity rose 9800.0% to 0.0% in Q3 2024 from the same period last year, while for Sep 2024 it was 0.0%, marking a year-over-year increase of 9800.0%. This contributed to the annual value of 0.8% for FY2023, which is 2800.0% up from last year.
- Per Palvella Therapeutics' latest filing, its Return on Equity stood at 0.0% for Q3 2024, which was up 9800.0% from 0.05% recorded in Q2 2024.
- Palvella Therapeutics' Return on Equity's 5-year high stood at 0.46% during Q4 2023, with a 5-year trough of 2.33% in Q1 2023.
- Moreover, its 5-year median value for Return on Equity was 0.99% (2021), whereas its average is 0.78%.
- In the last 5 years, Palvella Therapeutics' Return on Equity tumbled by -12800bps in 2023 and then skyrocketed by 22900bps in 2024.
- Quarter analysis of 5 years shows Palvella Therapeutics' Return on Equity stood at 0.89% in 2020, then decreased by -11bps to 0.99% in 2021, then tumbled by -35bps to 1.34% in 2022, then skyrocketed by 134bps to 0.46% in 2023, then plummeted by -101bps to 0.0% in 2024.
- Its Return on Equity stands at 0.0% for Q3 2024, versus 0.05% for Q2 2024 and 0.03% for Q1 2024.